CVS Health’s compact Houston pharmacy could reveal where America’s drugstores are heading
CVS Health opens a pharmacy-focused Houston store as its smaller format tests whether better access can coexist with stronger retail economics for patients.
CVS Health opens a pharmacy-focused Houston store as its smaller format tests whether better access can coexist with stronger retail economics for patients.
REGENXBIO reports five-year wet AMD durability and 2.5-year diabetic retinopathy data as pivotal sura-vec milestones approach.
MultiDimension Technology’s TMR1370 targets two-year CGM standby with 50 nA current, but device-level validation will decide its impact.
Salus Scientific gains a strategic tailwind as six medical societies urge hospitals to adopt enhanced radiation protection in fluoroscopy labs.
Eurofins Viracor adds rapid CXCL9, CXCL10 and IL-18 plasma assays, but clinical utility, logistics and reimbursement will shape adoption.
Vanda’s imsidolimab gains an EMA orphan recommendation for GPP, but approval, differentiation and European access remain ahead.
Camurus has restored a formal United States review timeline for CAM2029, but the December decision remains tied to third-party manufacturing compliance rather than new questions about clinical efficacy.
Trellis Bioscience raises $9 million to complete a Phase 2 trial testing calpurbatug and implant retention in chronic joint infections.
QIAGEN highlights its FDA-cleared QIAstat-Dx panel as U.S. Cyclospora cases rise, while research tools support outbreak tracing.
Nihon Kohden adds Pmus monitoring and adaptive controls to NKV-550, but hospital adoption will depend on validation and workflow performance.